Efficacy of Carbonic Anhydrase in Patients with X-Linked Retinoschisis

Efficacy of Carbonic Anhydrase in Patients wi...

Up next

Systemic Workup in Isolated Paracentral Acute Middle Maculopathy

Dr. Drew Carey interviews Dr. Avner Hostovsky on his study evaluating the diagnostic yield of a structured systemic workup in patients presenting with acute visual symptoms who were diagnosed with isolated paracentral acute middle maculopathy (PAMM). From his Ophthalmology articl ...  Show more

Detecting Inflammation in Fundus Photos Using Machine Learning

Dr. Drew Carey is joined by Drs. S. Saeed Mohammadi and Quan Dong Nguyen, authors of Ophthalmology Science's "Detecting Inflammation in Fundus Photographs Using Machine Learning." They discuss their study investigating the use of AI in the diagnosis of uveitis from ultra-widefiel ...  Show more

Recommended Episodes

#192 Debate on First-Line Medications for Diabetes
Core IM | Internal Medicine Podcast

SGLT-2i vs. GLP-1? vs Metformin? How do you balance the cost and coverage of first-line options like metformin, SGLT-2, and GLP-1s? How do you choose between SGLT-2 and GLP-1s for comorbidities like CAD or CKD? And how do you weigh their side effects and practical use?🔹 Sponsor: ...  Show more

#337 - Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment | Ralph DeFronzo, M.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/ ...

  Show more

S3 Episode 2: Treating Type 2 Diabetes in an Aging Population: Geriatric Syndromes, Comorbidities, and Treatment De-escalation
Medscape InDiscussion: Type 2 Diabetes

Drs Carol H. Wysham and Medha Munshi discuss type 2 diabetes in older adults, understanding geriatric syndromes and how they impact care, and when to de-escalate treatment. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarti ...  Show more

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Annals On Call Podcast

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.